6-32044149-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001365276.2(TNXB):c.11264-20G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.019 in 1,471,384 control chromosomes in the GnomAD database, including 548 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.016 ( 56 hom., cov: 19)
Exomes 𝑓: 0.019 ( 492 hom. )
Consequence
TNXB
NM_001365276.2 intron
NM_001365276.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.64
Publications
0 publications found
Genes affected
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNXB Gene-Disease associations (from GenCC):
- Ehlers-Danlos syndromeInheritance: AR Classification: DEFINITIVE Submitted by: G2P
- Ehlers-Danlos syndrome due to tenascin-X deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Illumina, PanelApp Australia, Orphanet
- familial vesicoureteral refluxInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- vesicoureteral reflux 8Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 6-32044149-C-T is Benign according to our data. Variant chr6-32044149-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 261104.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0162 (2150/132592) while in subpopulation NFE AF = 0.0235 (1443/61452). AF 95% confidence interval is 0.0225. There are 56 homozygotes in GnomAd4. There are 1059 alleles in the male GnomAd4 subpopulation. Median coverage is 19. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 56 AR,AD gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TNXB | NM_001365276.2 | c.11264-20G>A | intron_variant | Intron 33 of 43 | ENST00000644971.2 | NP_001352205.1 | ||
| TNXB | NM_001428335.1 | c.12005-20G>A | intron_variant | Intron 34 of 44 | NP_001415264.1 | |||
| TNXB | NM_019105.8 | c.11258-20G>A | intron_variant | Intron 33 of 43 | NP_061978.6 | |||
| TNXB | NM_032470.4 | c.551-20G>A | intron_variant | Intron 2 of 12 | NP_115859.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TNXB | ENST00000644971.2 | c.11264-20G>A | intron_variant | Intron 33 of 43 | NM_001365276.2 | ENSP00000496448.1 |
Frequencies
GnomAD3 genomes AF: 0.0163 AC: 2155AN: 132510Hom.: 57 Cov.: 19 show subpopulations
GnomAD3 genomes
AF:
AC:
2155
AN:
132510
Hom.:
Cov.:
19
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0185 AC: 3726AN: 201420 AF XY: 0.0187 show subpopulations
GnomAD2 exomes
AF:
AC:
3726
AN:
201420
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0192 AC: 25760AN: 1338792Hom.: 492 Cov.: 31 AF XY: 0.0192 AC XY: 12779AN XY: 665472 show subpopulations
GnomAD4 exome
AF:
AC:
25760
AN:
1338792
Hom.:
Cov.:
31
AF XY:
AC XY:
12779
AN XY:
665472
show subpopulations
African (AFR)
AF:
AC:
80
AN:
30612
American (AMR)
AF:
AC:
363
AN:
39516
Ashkenazi Jewish (ASJ)
AF:
AC:
492
AN:
24928
East Asian (EAS)
AF:
AC:
461
AN:
37624
South Asian (SAS)
AF:
AC:
1142
AN:
77604
European-Finnish (FIN)
AF:
AC:
1397
AN:
48426
Middle Eastern (MID)
AF:
AC:
87
AN:
4162
European-Non Finnish (NFE)
AF:
AC:
20787
AN:
1020046
Other (OTH)
AF:
AC:
951
AN:
55874
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.528
Heterozygous variant carriers
0
764
1527
2291
3054
3818
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
708
1416
2124
2832
3540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0162 AC: 2150AN: 132592Hom.: 56 Cov.: 19 AF XY: 0.0165 AC XY: 1059AN XY: 64068 show subpopulations
GnomAD4 genome
AF:
AC:
2150
AN:
132592
Hom.:
Cov.:
19
AF XY:
AC XY:
1059
AN XY:
64068
show subpopulations
African (AFR)
AF:
AC:
109
AN:
34388
American (AMR)
AF:
AC:
70
AN:
13230
Ashkenazi Jewish (ASJ)
AF:
AC:
62
AN:
3204
East Asian (EAS)
AF:
AC:
89
AN:
4554
South Asian (SAS)
AF:
AC:
50
AN:
3856
European-Finnish (FIN)
AF:
AC:
284
AN:
9026
Middle Eastern (MID)
AF:
AC:
6
AN:
274
European-Non Finnish (NFE)
AF:
AC:
1443
AN:
61452
Other (OTH)
AF:
AC:
25
AN:
1814
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.556
Heterozygous variant carriers
0
70
140
209
279
349
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.